Search Results - "Colaci, M."

Refine Results
  1. 1

    Nailfold capillaroscopic changes in dermatomyositis and polymyositis by Manfredi, A., Sebastiani, M., Cassone, G., Pipitone, N., Giuggioli, D., Colaci, M., Salvarani, C., Ferri, C.

    Published in Clinical rheumatology (01-02-2015)
    “…Inflammatory myopathies (IM) are a group of muscle diseases occurring both in children and adults. Nailfold videocapillaroscopy (NVC) alterations are described…”
    Get full text
    Journal Article
  2. 2

    Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: a multicentre validation study by Sebastiani, M, Manfredi, A, Vukatana, G, Moscatelli, S, Riato, L, Bocci, M, Iudici, M, Principato, A, Mazzuca, S, Del Medico, P, De Angelis, R, D'Amico, R, Vicini, R, Colaci, M, Ferri, C

    Published in Annals of the rheumatic diseases (01-01-2012)
    “…Introduction The early detection of systemic sclerosis (SSc) patients at high risk of developing digital ulcers could allow preventive treatment, with a…”
    Get more information
    Journal Article
  3. 3

    IP-10 in autoimmune thyroiditis by Ruffilli, I, Ferrari, S M, Colaci, M, Ferri, C, Fallahi, P, Antonelli, A

    Published in Hormone and metabolic research (01-08-2014)
    “…The interferon-γ-inducible protein 10 (IP-10) was initially identified as a chemokine that is induced by interferon (IFN)-γ. IP-10 exerts its function through…”
    Get more information
    Journal Article
  4. 4

    CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis—a longitudinal study by Antonelli, A., Ferri, C., Fallahi, P., Ferrari, S. M., Giuggioli, D., Colaci, M., Manfredi, A., Frascerra, S., Franzoni, F., Galetta, F., Ferrannini, E.

    Published in Rheumatology (Oxford, England) (01-01-2008)
    “…Objectives. To measure serum levels of CXCL10 and CCL2 chemokines in patients with SSc, and relate the findings to clinical phenotype and disease progression…”
    Get full text
    Journal Article
  5. 5

    Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature by Giuggioli, Dilia, Colaci, M., Cassone, G., Fallahi, P., Lumetti, F., Spinella, A., Campomori, F., Manfredi, A., Manzini, C. U., Antonelli, A., Ferri, C.

    Published in Clinical rheumatology (01-03-2017)
    “…Hypovitaminosis D is increasingly reported in autoimmune diseases. We investigated the 25-OH-vitamin D (25-OH-vitD) levels in systemic sclerosis (SSc)…”
    Get full text
    Journal Article
  6. 6

    Paraneoplastic rheumatic disorders: a narrative review by Manzini, C U, Colaci, M, Ferri, C, Manzini, E

    Published in Reumatismo (20-12-2018)
    “…Paraneoplastic syndromes (PS) are a heterogeneous group of diseases related to a neoplasm, indirectly dependent on it. Diagnosis and the treatment are often a…”
    Get full text
    Journal Article Book Review
  7. 7

    The safety of iloprost in systemic sclerosis in a real-life experience by Bellando-Randone, S., Bruni, C., Lepri, G., Fiori, G., Bartoli, F., Conforti, ML, Moggi-Pignone, A., Guiducci, S., Giuggioli, D., Colaci, M., Spinella, A., Ferri, C., Matucci-Cerinic, M.

    Published in Clinical rheumatology (01-05-2018)
    “…Iloprost (ILO) is employed intravenously for the treatment of severe Raynaud phenomenon (RP) and digital ulcers (DU) in systemic sclerosis (SSc). The aim of…”
    Get full text
    Journal Article
  8. 8
  9. 9

    HCV-related autoimmune disorders in HCV chronic infection by Ferrari, S M, Fallahi, P, Mancusi, C, Colaci, M, Manfredi, A, Ferri, C, Antonelli, A

    Published in Clinica terapeutica (2013)
    “…Patients with hepatitis C virus (HCV) chronic infection may develop a great number of extrahepatic manifestations. Among these latter, mixed cryoglobulinemia…”
    Get more information
    Journal Article
  10. 10

    Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients by Sebastiani, M., Manfredi, A., Colaci, M., D'amico, R., Malagoli, V., Giuggioli, D., Ferri, C.

    Published in Arthritis and rheumatism (15-05-2009)
    “…Objective Digital ulcerations are one of the most frequent manifestations of microangiopathy in patients with systemic sclerosis (SSc; scleroderma). The early…”
    Get full text
    Journal Article
  11. 11

    D-penicillamine in the treatment of eosinophilic fasciitis: case reports and review of the literature by Manzini, CU, Sebastiani, M, Giuggioli, D, Manfredi, A, Colaci, M, Cesinaro, AM, Ferri, C

    Published in Clinical rheumatology (01-01-2012)
    “…Eosinophilic fasciitis (EF) is a rare disease characterized by symmetrical thickness and hardening of the skin, especially localized to forearms and thorax,…”
    Get full text
    Journal Article
  12. 12

    Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia by Artoni, E, Sighinolfi, G L, Gatti, A M, Sebastiani, M, Colaci, M, Giuggioli, D, Ferri, C

    Published in Occupational medicine (Oxford) (01-01-2017)
    “…Mixed cryoglobulinemia (MC) is a rare multisystem disease whose aetiopathogenesis is not completely understood. Hepatitis C virus (HCV) infection may have a…”
    Get full text
    Journal Article
  13. 13

    Heart involvement and systemic sclerosis by Ferri, C, Giuggioli, D, Sebastiani, M, Colaci, M, Emdin, M

    Published in Lupus (01-01-2005)
    “…Scleroderma heart involvement (SHI) is often manifest, and virtually always present when accurately searched and holds a significant prognostic value…”
    Get full text
    Journal Article
  14. 14

    Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts by Antonelli, A., Ferri, C., Ferrari, S.M., Colaci, M., Ruffilli, I., Sebastiani, M., Fallahi, P.

    Published in British journal of dermatology (1951) (01-01-2013)
    “…Summary Background  No study has evaluated the effect of the peroxisome proliferator‐activated receptor γ (PPARγ) agonists on cell viability, proliferation and…”
    Get full text
    Journal Article
  15. 15

    Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature by Ferri, C., Vacchi, Caterina, Giuggioli, D., Colaci, Michele

    Published in Case reports in rheumatology (01-01-2017)
    “…Background. The association of systemic sclerosis (SSc) and haematological cancers was reported in a large number of case reports and cohort studies,…”
    Get full text
    Journal Article
  16. 16

    Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature by Colaci, Michele, Giuggioli, Dilia, Manfredi, Andreina, Vacchi, Caterina, Della Casa, Giovanni, Ferri, Clodoveo

    Published in Rheumatology (Oxford, England) (01-04-2014)
    “…Thymus alterations have been related to several autoimmune disorders. In particular, previous studies identified a significant frequency of gland abnormalities…”
    Get full text
    Journal Article
  17. 17

    Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin by Ferri, C., Giuggioli, D., Sebastiani, M., Colaci, M.

    Published in Clinical and experimental dermatology (01-05-2007)
    “…Summary Systemic sclerosis (SSc) is frequently complicated by skin ulcers, often unresponsive to traditional treatments. A preliminary evaluation of the…”
    Get full text
    Journal Article
  18. 18

    Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline by Colaci, M, Giuggioli, D, Sebastiani, M, Manfredi, A, Lumetti, F, Luppi, F, Cerri, S, Ferri, C

    Published in Reumatismo (23-12-2015)
    “…Impaired diffusing capacity of the lung for carbon monoxide (DLCO) was frequently observed in systemic sclerosis (SSc) patients, generally related to the…”
    Get full text
    Journal Article
  19. 19

    Aortic pulse wave velocity measurement in systemic sclerosis patients by Colaci, M, Giuggioli, D, Manfredi, A, Sebastiani, M, Coppi, F, Rossi, R, Ferri, C

    Published in Reumatismo (31-12-2012)
    “…Systemic sclerosis (SSc) is characterized by endothelial dysfunction and widespread microangiopathy. However, a macrovascular damage could be also associated…”
    Get full text
    Journal Article
  20. 20

    Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature by Ferri, C., Manfredi, Andreina, Boselli, F., Campomori, Federica, Vacchi, C., Cassone, Giulia, Giuggioli, Dilia, Colaci, Michele, Sebastiani, Marco

    Published in International Journal of Rheumatology (01-01-2015)
    “…Background. Increased incidence of cancer was frequently reported in scleroderma (SSc), but no association with gynaecological malignancies was described in…”
    Get full text
    Journal Article